Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1

Background Acute kidney injury (AKI) is a common complication of cardiac surgery. Human umbilical cord mesenchymal stem cell (hUCMSC)-derived exosomes affect tissue damage and repair, and miR-21-5p reduces apoptosis and inflammation. However, miR-21-5p’s role in cardiac surgery remains unclear.Metho...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengmin Li, Fang He, Shuyang Dai, Qingqing Yu, Chenchen Si, Fan Wu, Wenxin Zhao, Biyao Zhang, Poshi Xu
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2025.2537797
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396603018805248
author Zhengmin Li
Fang He
Shuyang Dai
Qingqing Yu
Chenchen Si
Fan Wu
Wenxin Zhao
Biyao Zhang
Poshi Xu
author_facet Zhengmin Li
Fang He
Shuyang Dai
Qingqing Yu
Chenchen Si
Fan Wu
Wenxin Zhao
Biyao Zhang
Poshi Xu
author_sort Zhengmin Li
collection DOAJ
description Background Acute kidney injury (AKI) is a common complication of cardiac surgery. Human umbilical cord mesenchymal stem cell (hUCMSC)-derived exosomes affect tissue damage and repair, and miR-21-5p reduces apoptosis and inflammation. However, miR-21-5p’s role in cardiac surgery remains unclear.Methods Kidney injury molecule (KIM-1), neutrophil gelatinase-associated lipid carrier protein (NGAL), serum creatinine, and blood urea nitrogen (BUN) levels were tested by enzyme-linked immunosorbent assay. hUCMSCs and exosomes were identified via Oil Red O staining kit, alkaline phosphatase staining kit, flow cytometry, transmission electron microscopy, Western blot, and immunofluorescence. Cell viability and apoptosis were detected by cell counting kit 8 and flow cytometry. Interleukin-1β, interleukin-6, and tumor necrosis factor-alpha levels were tested by ELISA kits. Relativity between miR-21-5p and TEA domain family member 1 (TEAD1) was verified by dual-luciferase reporter gene assay and western blot. TEAD1, BUN, and creatinine levels in vivo were tested via immunohistochemistry and automatic biochemistry analyzer.Results KIM-1, NGAL, serum creatinine, and BUN levels were increased and miR-21-5p expression was inhibited in AKI after cardiac surgery. In AKI after cardiac surgery, hUCMSCs-Exos inhibited apoptosis and pyroptosis and promoted viability via miR-21-5p regulation. hUCMSCs-Exos retarded AKI after cardiac surgery progression by facilitating miR-21-5p targeting of TEAD1. hUCMSCs-Exos promoted miR-21-5p and inhibited TEAD1 expression in vivo. miR-21-5p knockdown facilitated TEAD1 expression in vivo. Results were exactly the same in vivo and in vitro AKI models.Conclusions hUCMSCs-Exos protect against AKI by enhancing miR-21-5p/TEAD1 binding in vivo and in vitro.
format Article
id doaj-art-7ababf72c6f848e38bc3dceb0e6af677
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-7ababf72c6f848e38bc3dceb0e6af6772025-08-20T03:39:18ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2025.2537797Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1Zhengmin Li0Fang He1Shuyang Dai2Qingqing Yu3Chenchen Si4Fan Wu5Wenxin Zhao6Biyao Zhang7Poshi Xu8Department of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaOperating Room, Woman & Infants Hospital of Zhengzhou, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaDepartment of Medical Laboratory, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, ChinaBackground Acute kidney injury (AKI) is a common complication of cardiac surgery. Human umbilical cord mesenchymal stem cell (hUCMSC)-derived exosomes affect tissue damage and repair, and miR-21-5p reduces apoptosis and inflammation. However, miR-21-5p’s role in cardiac surgery remains unclear.Methods Kidney injury molecule (KIM-1), neutrophil gelatinase-associated lipid carrier protein (NGAL), serum creatinine, and blood urea nitrogen (BUN) levels were tested by enzyme-linked immunosorbent assay. hUCMSCs and exosomes were identified via Oil Red O staining kit, alkaline phosphatase staining kit, flow cytometry, transmission electron microscopy, Western blot, and immunofluorescence. Cell viability and apoptosis were detected by cell counting kit 8 and flow cytometry. Interleukin-1β, interleukin-6, and tumor necrosis factor-alpha levels were tested by ELISA kits. Relativity between miR-21-5p and TEA domain family member 1 (TEAD1) was verified by dual-luciferase reporter gene assay and western blot. TEAD1, BUN, and creatinine levels in vivo were tested via immunohistochemistry and automatic biochemistry analyzer.Results KIM-1, NGAL, serum creatinine, and BUN levels were increased and miR-21-5p expression was inhibited in AKI after cardiac surgery. In AKI after cardiac surgery, hUCMSCs-Exos inhibited apoptosis and pyroptosis and promoted viability via miR-21-5p regulation. hUCMSCs-Exos retarded AKI after cardiac surgery progression by facilitating miR-21-5p targeting of TEAD1. hUCMSCs-Exos promoted miR-21-5p and inhibited TEAD1 expression in vivo. miR-21-5p knockdown facilitated TEAD1 expression in vivo. Results were exactly the same in vivo and in vitro AKI models.Conclusions hUCMSCs-Exos protect against AKI by enhancing miR-21-5p/TEAD1 binding in vivo and in vitro.https://www.tandfonline.com/doi/10.1080/0886022X.2025.2537797Human umbilical cord mesenchymal stem cellsexosomesmiR-21-5pTEA domain family member 1acute kidney injury
spellingShingle Zhengmin Li
Fang He
Shuyang Dai
Qingqing Yu
Chenchen Si
Fan Wu
Wenxin Zhao
Biyao Zhang
Poshi Xu
Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1
Renal Failure
Human umbilical cord mesenchymal stem cells
exosomes
miR-21-5p
TEA domain family member 1
acute kidney injury
title Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1
title_full Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1
title_fullStr Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1
title_full_unstemmed Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1
title_short Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate AKI after cardiac surgery by facilitating miR-21-5p targeting TEAD1
title_sort exosomes derived from human umbilical cord mesenchymal stem cells ameliorate aki after cardiac surgery by facilitating mir 21 5p targeting tead1
topic Human umbilical cord mesenchymal stem cells
exosomes
miR-21-5p
TEA domain family member 1
acute kidney injury
url https://www.tandfonline.com/doi/10.1080/0886022X.2025.2537797
work_keys_str_mv AT zhengminli exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT fanghe exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT shuyangdai exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT qingqingyu exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT chenchensi exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT fanwu exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT wenxinzhao exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT biyaozhang exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1
AT poshixu exosomesderivedfromhumanumbilicalcordmesenchymalstemcellsameliorateakiaftercardiacsurgerybyfacilitatingmir215ptargetingtead1